Nippon Pharmaceuticuals (India) Private Limited
Trading ayurvedic products since 1980, based in Chennai, Tamil Nadu.
1980 | Kanchipuram, Tamil Nadu (India) | Active
Nippon Pharmaceuticuals (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.88 M
- Company Age 45 Year, 12 Days
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 20.00 K
- Revenue Growth -28.29%
- Profit Growth -12.81%
- Ebitda -12.81%
- Net Worth -25.85%
- Total Assets -25.34%
About Nippon Pharmaceuticuals (India)
Nippon Pharmaceuticuals (India) Private Limited (NPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 February 1980 and has a history of 45 years. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.88 M.
The company currently has active open charges totaling ₹20,000.00.
Vijay Anand and Mahalakshmi serve as directors at the Company.
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230TN1980PTC008130
- Company No.
008130
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Feb 1980
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Healthcare
Who are the key members and board of directors at Nippon Pharmaceuticuals (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Anand  | Additional Director | 11-Apr-2022 | Current |
| Mahalakshmi | Additional Director | 11-Apr-2022 | Current |
Financial Performance of Nippon Pharmaceuticuals (India).
Nippon Pharmaceuticuals (India) Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 28.29% decrease. The company also saw a substantial fall in profitability, with a 12.81% decrease in profit. The company's net worth observed a substantial decline by a decrease of 25.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nippon Pharmaceuticuals (India)?
In 2021, Nippon Pharmaceuticuals (India) had a promoter holding of 55.52% and a public holding of 44.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹0.02 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 0.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Aug 1986 | Indian Bank | ₹0.02 M | Open |
How Many Employees Work at Nippon Pharmaceuticuals (India)?
Unlock and access historical data on people associated with Nippon Pharmaceuticuals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nippon Pharmaceuticuals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nippon Pharmaceuticuals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
